Delivery Order SPE2DB24D3013-SPE2DB25FFNMF
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,401.40 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Lisdexamfetamine 30 mg capsules (100 count). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 29, 2025. The contract is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,111.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100 count). This delivery order is not set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for Lisdexamfetamine 20 mg capsules (100-count units) with a ceiling value of $2,587.33. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The order is set to complete by July 25, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $1,242.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Lisdexamfetamine 50 mg capsules in quantities of 100. The contract is non-set-aside and competitively awarded, with an ultimate completion date of July 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order, which falls under the company's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Lisdexamfetamine 50 mg capsules (100 count) with a ceiling value of $2,140.20. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 29, 2025. This delivery order is...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Lisdexamfetamine 50 mg capsules in a quantity of 90 units, with a ceiling value of $3,364.35. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and requires delivery by July 28, 2025, to Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order is a child contract under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,198.41 for Lisdexamfetamine 40 mg capsules (100 count) on July 28, 2025, with completion expected by July 29, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The pharmaceutical product will be delivered to the company's distribution facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Lisdexamfetamine 60 mg capsules (100-count) with a ceiling value of $1,792.80. This firm fixed-price delivery order, with an ultimate completion date of July 24, 2025, represents a competitive award with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,442.92 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 50 mg capsules (100 count) on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Lisdexamfetamine 10 mg capsules (100 count) with a ceiling value of $1,501.54. This firm fixed-price delivery order, which must be completed by July 21, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award carries no set-aside...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFNMFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100 count) with a ceiling value of $2,031.40. This is a firm fixed-price delivery order with no set-aside designation, reflecting AmerisourceBergen's capability to compete successfully in open federal procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime pharmaceutical contract vehicle enables AmerisourceBergen to supply a comprehensive range of medications and medical supplies to support military healthcare systems globally. The Lisdexamfetamine delivery supports the Defense Health Agency and other federal healthcare customers' pharmaceutical needs, consistent with AmerisourceBergen's established role as a critical pharmaceutical distributor for federal medical procurement, with a final completion date of July 22, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 7/21/25 |